These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23946347)

  • 21. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Studies of Water-Insoluble β-Glucan from Oat Bran and Its Effect on Improving Lipid Metabolism in Mice Fed High-Fat Diet.
    Yu S; Wang J; Li Y; Wang X; Ren F; Wang X
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of beta glucan in highland barley on blood glucose and serum lipid in high fat-induced C57 mouse].
    Tian MJ; Song JN; Liu PP; Su LH; Sun CH; Li Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jan; 47(1):55-8. PubMed ID: 23601524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women.
    Behall KM; Scholfield DJ; Hallfrisch J
    J Am Coll Nutr; 1997 Feb; 16(1):46-51. PubMed ID: 9013433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 6 weeks' consumption of β-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults.
    Charlton KE; Tapsell LC; Batterham MJ; O'Shea J; Thorne R; Beck E; Tosh SM
    Br J Nutr; 2012 Apr; 107(7):1037-47. PubMed ID: 21810288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supplementation of a high-carbohydrate breakfast with barley beta-glucan improves postprandial glycaemic response for meals but not beverages.
    Poppitt SD; van Drunen JD; McGill AT; Mulvey TB; Leahy FE
    Asia Pac J Clin Nutr; 2007; 16(1):16-24. PubMed ID: 17215176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular structure of large-scale extracted β-glucan from barley and oat: Identification of a significantly changed block structure in a high β-glucan barley mutant.
    Mikkelsen MS; Jespersen BM; Larsen FH; Blennow A; Engelsen SB
    Food Chem; 2013 Jan; 136(1):130-8. PubMed ID: 23017403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viscosity of oat bran-enriched beverages influences gastrointestinal hormonal responses in healthy humans.
    Juvonen KR; Purhonen AK; Salmenkallio-Marttila M; Lähteenmäki L; Laaksonen DE; Herzig KH; Uusitupa MI; Poutanen KS; Karhunen LJ
    J Nutr; 2009 Mar; 139(3):461-6. PubMed ID: 19176745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects.
    Zhu X; Sun X; Wang M; Zhang C; Cao Y; Mo G; Liang J; Zhu S
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):714-23. PubMed ID: 26026211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol-lowering properties of oat β-glucan and the promotion of cardiovascular health: did Health Canada make the right call?
    Nwachukwu ID; Devassy JG; Aluko RE; Jones PJ
    Appl Physiol Nutr Metab; 2015 Jun; 40(6):535-42. PubMed ID: 25933163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barley β-glucan increases fecal bile acid excretion and short chain fatty acid levels in mildly hypercholesterolemic individuals.
    Thandapilly SJ; Ndou SP; Wang Y; Nyachoti CM; Ames NP
    Food Funct; 2018 Jun; 9(6):3092-3096. PubMed ID: 29872803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians.
    Wolever TM; Gibbs AL; Brand-Miller J; Duncan AM; Hart V; Lamarche B; Tosh SM; Duss R
    Nutr J; 2011 Nov; 10():130. PubMed ID: 22118569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men.
    Keogh GF; Cooper GJ; Mulvey TB; McArdle BH; Coles GD; Monro JA; Poppitt SD
    Am J Clin Nutr; 2003 Oct; 78(4):711-8. PubMed ID: 14522728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.
    Braaten JT; Wood PJ; Scott FW; Wolynetz MS; Lowe MK; Bradley-White P; Collins MW
    Eur J Clin Nutr; 1994 Jul; 48(7):465-74. PubMed ID: 7956987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials.
    AbuMweis SS; Jew S; Ames NP
    Eur J Clin Nutr; 2010 Dec; 64(12):1472-80. PubMed ID: 20924392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction
    Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V
    Eur J Clin Nutr; 2016 Nov; 70(11):1239-1245. PubMed ID: 27273067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oat bran, processed to different molecular weights of beta-glucan, on plasma lipids and caecal formation of SCFA in mice.
    Immerstrand T; Andersson KE; Wange C; Rascon A; Hellstrand P; Nyman M; Cui SW; Bergenståhl B; Trägårdh C; Oste R
    Br J Nutr; 2010 Aug; 104(3):364-73. PubMed ID: 20334710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity.
    Panahi S; Ezatagha A; Temelli F; Vasanthan T; Vuksan V
    J Am Coll Nutr; 2007 Dec; 26(6):639-44. PubMed ID: 18187427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-grain cereal products based on a high-fibre barley or oat genotype lower post-prandial glucose and insulin responses in healthy humans.
    Alminger M; Eklund-Jonsson C
    Eur J Nutr; 2008 Sep; 47(6):294-300. PubMed ID: 18633670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yeast-leavened oat breads with high or low molecular weight beta-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans.
    Frank J; Sundberg B; Kamal-Eldin A; Vessby B; Aman P
    J Nutr; 2004 Jun; 134(6):1384-8. PubMed ID: 15173400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.